IM Cannabis Corp. current report, Q2 FY2022

IM Cannabis Corp. — Form 6-K Summary

Business context and reporting period

IM Cannabis Corp., an Israel-based foreign private issuer, filed a Form 6-K for April 2022. The filing is dated April 14, 2022 and identifies Exhibit 99.1 as a Form 51-102F3 Material Change Report dated April 14, 2022. The supplied filing text contains the Form 6-K cover page and exhibit index but not the contents of the material change report.

Financial and operating metrics

The supplied text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, operating performance, or other financial metrics.

Material changes versus the prior comparable period

The filing identifies a material change report as Exhibit 99.1, but the underlying report is not included in the supplied content. Accordingly, the nature and financial impact of any material change cannot be determined.

Guidance, outlook, risks, contingencies, and unusual items

No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the supplied text.

Important facts for investors to verify

  • Obtain and review Exhibit 99.1, the Form 51-102F3 Material Change Report dated April 14, 2022.
  • Verify the nature, timing, and financial impact of the reported material change.
  • Review any related disclosures regarding liquidity, financing, obligations, risks, or outlook.
  • Note that Exhibit 99.1 is incorporated by reference into the company’s Form F-10 registration statement, File No. 333-254255.